trending Market Intelligence /marketintelligence/en/news-insights/trending/SN96RkKBoAH3CC6-7HlW7w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Cogstate to raise A$4M for potential international expansion

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Cogstate to raise A$4M for potential international expansion

Cogstate Ltd. launched a 1-for-10 entitlement offer of new shares to raise about A$4 million for international expansion.

The Australian healthcare technology company will offer common shares at 27 Australian cents each to existing investors in the company.

Cogstate, which recently raised A$2.9 million through a share placement deal with Japanese drugmaker Eisai Co. Ltd., plans to use the net proceeds from the entitlement offer to carry out similar deals in Japan as well as other countries.

A part of the proceeds will also be used to further the company's technology, including mobile applications, further region-specific product adaption and general working capital, Cogstate said in an Oct. 21 press release.

Cogstate provides computerized cognitive tests for clinical trials, research and brain injury applications.